These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11224241)

  • 21. Evaluation of the interaction between D1 and D2 receptors in a drug discrimination paradigm.
    Williams JE; Sutherland JV; Woolverton WL
    Behav Neural Biol; 1990 May; 53(3):378-92. PubMed ID: 1972014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the dopamine D1 receptor antagonist SCH 39166 on the ingestive behaviour of alcohol-preferring rats.
    Panocka I; Ciccocioppo R; Mosca M; Polidori C; Massi M
    Psychopharmacology (Berl); 1995 Jul; 120(2):227-35. PubMed ID: 7480557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of D2 dopamine receptor blockade with raclopride on intracranial self-stimulation and food-reinforced operant behaviour.
    Nakajima S; Baker JD
    Psychopharmacology (Berl); 1989; 98(3):330-3. PubMed ID: 2501812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD; Pierce RC
    Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of extinction, pimozide, SCH 23390, and metoclopramide on food-rewarded operant responding of rats.
    Beninger RJ; Cheng M; Hahn BL; Hoffman DC; Mazurski EJ; Morency MA; Ramm P; Stewart RJ
    Psychopharmacology (Berl); 1987; 92(3):343-9. PubMed ID: 2957718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two directions of dopamine D1/D2 receptor interaction in studies of behavioural regulation: a finding generic to four new, selective dopamine D1 receptor antagonists.
    Daly SA; Waddington JL
    Eur J Pharmacol; 1992 Mar; 213(2):251-8. PubMed ID: 1387846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat.
    Koob GF; Le HT; Creese I
    Neurosci Lett; 1987 Aug; 79(3):315-20. PubMed ID: 2958724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naltrexone, dopamine receptor agonists and antagonists, and food intake in rats: 1. Food deprivation.
    Hobbs DJ; Koch JE; Bodnar RJ
    Pharmacol Biochem Behav; 1994 Sep; 49(1):197-204. PubMed ID: 7816874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attenuation of sucrose reinforcement in dopamine D1 receptor deficient mice.
    El-Ghundi M; O'Dowd BF; Erclik M; George SR
    Eur J Neurosci; 2003 Feb; 17(4):851-62. PubMed ID: 12603275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.
    Iorio LC; Cohen M; Coffin VL
    J Pharmacol Exp Ther; 1991 Jul; 258(1):118-23. PubMed ID: 1830098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-administration of dopamine D1 and D2 agonists additively decreases daily food intake, body weight and hypothalamic neuropeptide Y level in rats.
    Kuo DY
    J Biomed Sci; 2002; 9(2):126-32. PubMed ID: 11914579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amphetamine reinstates polydipsia induced by chronic exposure to quinpirole, a dopaminergic D2 agonist, in rats.
    Fraioli S; Cioli I; Nencini P
    Behav Brain Res; 1997 Dec; 89(1-2):199-215. PubMed ID: 9475627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of a range of dopamine receptor agonists and antagonists on ethanol intake in the rat.
    Silvestre JS; O'Neill MF; Fernandez AG; Palacios JM
    Eur J Pharmacol; 1996 Dec; 318(2-3):257-65. PubMed ID: 9016913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of a D1 and a D2 dopamine antagonist on behavior maintained by cocaine or food.
    Woolverton WL; Virus RM
    Pharmacol Biochem Behav; 1989 Mar; 32(3):691-7. PubMed ID: 2662223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopaminergic control of angiotensin II-induced vasopressin secretion in vitro.
    Rossi NF
    Am J Physiol; 1998 Oct; 275(4):E687-93. PubMed ID: 9755089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats.
    Munzar P; Goldberg SR
    Psychopharmacology (Berl); 2000 Feb; 148(2):209-16. PubMed ID: 10663437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the dopamine D1-like receptor antagonist SCH 23390 on the microstructure of ingestive behaviour in water-deprived rats licking for water and NaCl solutions.
    Galistu A; D'Aquila PS
    Physiol Behav; 2012 Jan; 105(2):230-3. PubMed ID: 21864553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. D1 but not D2 dopamine receptor antagonism blocks the acquisition of a flavor preference conditioned by intragastric carbohydrate infusions.
    Azzara AV; Bodnar RJ; Delamater AR; Sclafani A
    Pharmacol Biochem Behav; 2001 Apr; 68(4):709-20. PubMed ID: 11526968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of D1- and D2-like compounds on cocaine self-administration in Lewis and Fischer 344 inbred rats.
    Haile CN; Kosten TA
    J Pharmacol Exp Ther; 2001 Nov; 299(2):509-18. PubMed ID: 11602661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.